News

Why randomized controlled trials are crucial for evaluating COVID-19 treatments

In the first few months of the COVID-19 pandemic, physicians and researchers scrambled to find drugs that might help COVID-19 patients based on their knowledge of drugs’ mechanisms, preliminary results from laboratory studies, and their emerging understanding of the disease. Dozens of treatments were tried within weeks and many of these treatments looked very promising as large proportions of patients improved on them.

Read More
Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left